James R Sulat - Net Worth and Insider Trading
James R Sulat Net Worth
The estimated net worth of James R Sulat is at least $9,906 dollars as of 2024-11-13. James R Sulat is the Director of Mallinckrodt PLC and owns about 82,553 shares of Mallinckrodt PLC (MCKPF) stock worth over $9,906. Details can be seen in James R Sulat's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James R Sulat has not made any transactions after 2023-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James R Sulat
James R Sulat Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James R Sulat owns 8 companies in total, including Arch Therapeutics Inc (ARTH) , AMAG Pharmaceuticals Inc (AMAG) , and Momenta Pharmaceuticals Inc (MNTA) among others .
Click here to see the complete history of James R Sulat’s form 4 insider trades.
Insider Ownership Summary of James R Sulat
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARTH | Arch Therapeutics Inc | 2019-12-20 | director |
| AMAG | AMAG Pharmaceuticals Inc | 2020-06-02 | director |
| MNTA | Momenta Pharmaceuticals Inc | 2019-06-19 | director |
 | | 2010-04-21 | director & 10 percent owner |
| | 2004-03-02 | Executive Vice President |
| | 2021-01-02 | director |
| | 2022-06-16 | director |
| | 2023-03-15 | director |
James R Sulat Latest Holdings Summary
James R Sulat currently owns a total of 1 stock. James R Sulat owns 82,553 shares of Mallinckrodt PLC (MCKPF) as of March 15, 2023, with a value of $9,906.
Latest Holdings of James R Sulat
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MCKPF | Mallinckrodt PLC | 2023-03-15 | 82,553 | 0.12 | 9,906 |
Holding Weightings of James R Sulat
James R Sulat Form 4 Trading Tracker
According to the SEC Form 4 filings, James R Sulat has made a total of 1 transactions in Mallinckrodt PLC (MCKPF) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Mallinckrodt PLC is the acquisition of 30,000 shares on March 15, 2023, which cost James R Sulat around $254,400.
Insider Trading History of James R Sulat
- 1
James R Sulat Trading Performance
GuruFocus tracks the stock performance after each of James R Sulat's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James R Sulat is -89.58%. GuruFocus also compares James R Sulat's trading performance to market benchmark return within the same time period. The performance of stocks bought by James R Sulat within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James R Sulat's insider trading performs compared to the benchmark.
Performance of James R Sulat
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -34.13 | | | | | |
| Relative Return to S&P 500(%) | -40.44 | | | | | |
James R Sulat Ownership Network
Ownership Network List of James R Sulat
Ownership Network Relation of James R Sulat
James R Sulat Owned Company Details
What does Arch Therapeutics Inc do?
Who are the key executives at Arch Therapeutics Inc?
James R Sulat is the director of Arch Therapeutics Inc. Other key executives at Arch Therapeutics Inc include director & President & CEO Terrence W Norchi , CFO and Treasurer Michael S Abrams , and Vice President & Sales Dan Yrigoyen .
Arch Therapeutics Inc (ARTH) Insider Trades Summary
Over the past 18 months, James R Sulat made no insider transaction in Arch Therapeutics Inc (ARTH). Other recent insider transactions involving Arch Therapeutics Inc (ARTH) include a net purchase of 10,292 shares made by Laurence Hicks , a net purchase of 10,292 shares made by Michael S Abrams , and a net purchase of 6,862 shares made by Terrence W Norchi .
In summary, during the past 3 months, insiders sold 0 shares of Arch Therapeutics Inc (ARTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arch Therapeutics Inc (ARTH) were sold and 27,446 shares were bought by its insiders, resulting in a net purchase of 27,446 shares.
Arch Therapeutics Inc (ARTH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arch Therapeutics Inc Insider Transactions
James R Sulat Mailing Address
Above is the net worth, insider trading, and ownership report for James R Sulat. Currently GuruFocus does not have mailing address information for James R Sulat.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
